Hepatobiliary & Pancreatic Diseases International
Scope & Guideline
Championing excellence in hepatobiliary and pancreatic research.
Introduction
Aims and Scopes
- Liver Diseases and Transplantation:
The journal emphasizes research on various liver diseases, including hepatocellular carcinoma, liver cirrhosis, and liver transplantation techniques. It aims to improve understanding of disease mechanisms and enhance surgical and therapeutic approaches. - Pancreatic Disorders:
There is a significant focus on pancreatic diseases, particularly pancreatic cancer and pancreatitis. The journal publishes studies on diagnosis, treatment strategies, and novel surgical techniques related to these conditions. - Biliary Pathology:
Research on biliary diseases, including cholangiocarcinoma and complications from biliary interventions, is a core area. The journal explores both surgical and non-surgical management options. - Innovative Surgical Techniques:
The journal highlights advancements in surgical methods, including minimally invasive techniques and robotic surgery, aimed at improving patient outcomes in liver and pancreatic surgeries. - Clinical and Translational Research:
Emphasizing the bridge between laboratory research and clinical application, the journal encourages studies that translate scientific findings into practical treatments for liver and pancreatic diseases. - Immunotherapy and Molecular Approaches:
There is a growing interest in the role of immunotherapy and molecular biology in the treatment of hepatobiliary and pancreatic cancers, reflecting modern therapeutic strategies.
Trending and Emerging
- Personalized Medicine and Genomics:
There is an increasing focus on personalized medicine approaches, including genomic profiling and tailored therapies for hepatobiliary and pancreatic cancers, reflecting the trend towards individualized patient care. - Immunotherapy Advances:
Research on immunotherapy, including checkpoint inhibitors and novel immunotherapeutic strategies, has gained significant traction, highlighting its potential in treating liver and pancreatic cancers. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning for diagnostics and treatment predictions is on the rise, showcasing innovations in data-driven approaches to hepatobiliary and pancreatic diseases. - Multidisciplinary Approaches to Treatment:
Emerging themes include collaborative, multidisciplinary approaches to managing complex cases in hepatobiliary and pancreatic surgery, integrating surgical, medical, and supportive care. - Microbiome and Liver Health:
Research exploring the relationship between the gut microbiome and liver disease is gaining attention, indicating a growing interest in the microbiome's role in health and disease. - Regenerative Medicine and Stem Cell Therapy:
There is an increasing exploration of regenerative medicine and stem cell therapy as potential treatments for liver diseases, reflecting advancements in biological therapies.
Declining or Waning
- Traditional Surgical Techniques:
There appears to be a waning emphasis on traditional open surgical techniques for hepatobiliary and pancreatic surgeries, as the field increasingly adopts minimally invasive and robotic approaches. - Conventional Imaging Techniques:
With the advent of advanced imaging modalities and radiomics, traditional imaging methods for diagnosing liver and pancreatic diseases are becoming less prominent in the journal's publications. - Single-Agent Chemotherapies:
Research focused solely on single-agent chemotherapy regimens for hepatobiliary malignancies has decreased, likely due to the shift towards combination therapies and personalized medicine. - Basic Science Studies:
There is a noticeable decline in basic science studies that do not directly translate to clinical practice, as the journal prioritizes research with immediate clinical applicability. - Epidemiological Studies without Novel Insights:
Epidemiological studies that do not provide new insights or advancements in understanding disease mechanisms or treatment are becoming less frequent.
Similar Journals
Hepatobiliary Surgery and Nutrition
Advancing the frontiers of liver health.Hepatobiliary Surgery and Nutrition is a leading journal dedicated to advancing the fields of hepatobiliary surgery and nutritional science, published by AME Publishing Company. With a commitment to disseminate high-quality research, this journal serves as a vital platform for clinicians, researchers, and students alike to share their findings and insights related to liver and biliary health. The journal operates under an Open Access model, ensuring that cutting-edge research is readily available to a global audience. Although specific rankings and impact factors are currently not provided, the journal's focus on innovative surgical techniques and nutritional strategies underscores its importance in improving patient outcomes and shaping future practices in hepatobiliary medicine. Situated in Hong Kong, Hepatobiliary Surgery and Nutrition invites submissions that push the boundaries of knowledge in these crucial areas, fostering a collaborative environment for advancement in surgery and nutrition.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Elevating clinical practices through open access knowledge.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
United European Gastroenterology Journal
Bridging research and practice for clinical excellence.The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.
JHEP Reports
Advancing healthcare knowledge through open access.JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Driving excellence in gastrointestinal and liver disease studies.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Expert Review of Gastroenterology & Hepatology
Navigating the Evolving Landscape of Digestive MedicineExpert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.
Annals of Hepato-Biliary-Pancreatic Surgery
Exploring Breakthroughs in Surgical PracticeAnnals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.
Pancreatology
Connecting Research and Clinical Practice in PancreatologyPancreatology is a prestigious journal published by ELSEVIER, focusing on the multifaceted disciplines of endocrinology, diabetes, gastroenterology, and hepatology since its inception in 2001. With an impressive Q1 ranking in multiple categories, including Endocrinology and Gastroenterology, Pancreatology stands out as a critical platform for disseminating peer-reviewed research that contributes to the evolving understanding of pancreatic diseases and associated metabolic disorders. This journal has gained significant recognition in the academic community, underscored by its robust Scopus rankings, positioning it favorably among its peers. While it currently does not offer open access, Pancreatology remains committed to advancing knowledge through high-quality publications and fostering innovation in clinical practice and research. Researchers, professionals, and students are invited to engage with the cutting-edge findings within its pages, which are essential for driving progress in this essential area of medicine.
HPB
Empowering innovation in clinical practice and policy.HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.
Gastroenterologia y Hepatologia
Connecting scholars to the forefront of gastroenterology and hepatology.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.